Abstract
The aim of this study was to investigate the factors in feasibility and safety of same-day dismissal (SDD) of endometrial cancer patients undergoing robotic hysterectomy and staging. A single-institution retrospective chart review of endometrial cancer patients who underwent robotic hysterectomy and staging between 2012 and 2021 was performed. Patient demographics, medical and surgical history, intra- and postoperative events were examined as possible factors related to non-SDD. These factors were analyzed using univariate (chi-square test) and multivariate logistic regression analysis. Of the 292 patients, 117 (40%) had SDD, and 175 (60%) had non-SDD. The SDD rate increased from 13.8% to 88% over the 10-year study period. The factors significantly associated with non-SDD (p < 0.05) were surgery in the first 5 years after the introduction of the SDD and ERAS protocols (2012–2016), age > 75 years, and comorbidities such as cardiovascular diseases, anemia (Hb < 11 g/dl), and anticoagulant therapy. Extensive adhesiolysis, the performance of complete pelvic and/or aortic lymphadenectomy, operating time > 180 min, and PACU discharge after 2:00 p.m. were significant factors for non-SDD. Sentinel lymph node sampling was significantly associated with SDD (OR 0.050; CI 0.273–0.934, p = 0.029). We reported no significant difference in the number, setting and timing of any unscheduled postoperative contacts, complications, and readmissions between SDD and non-SDD groups. SDD after robotic hysterectomy and staging for endometrial cancer is feasible and safe. There are patient and surgery factors for the failure of SDD. The sentinel lymph node sampling was significantly associated with achieving SDD. Trial registration: Institutional Review Board approved the study protocol (#: 1764–05).
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Spiegel G, Barakat R, Pearl ML, Sharma SK (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2. J Clin Oncol 27(32):5331–5336
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Barakat R, Pearl ML, Sharma SK (2012) Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group LAP2 study. J Clin Oncol 30(7):695–700
Yu X, Lum D, Kiet TK, Fuh KC, Orr J Jr, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK (2013) Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol 107(6):653–658
La Verde M, Riemma G, Tropea A, Biondi A, Cianci S (2022) Ultra-minimally invasive surgery in gynecological patients: a review of the literature. Updates Surg 74(3):843–855
Park HK, Helenowski IB, Berry E, Lurain JR, Neubauer NL (2015) A Comparison of survival and recurrence outcomes in patients with endometrial cancer undergoing robotic versus open surgery. J Minim Invasive Gynecol 22(6):961–967
Vitale SG, Laganà AS, Caruso S, Garzon S, Vecchio GM, La Rosa VL, Casarin J, Ghezzi F (2021) Comparison of three biopsy forceps for hysteroscopic endometrial biopsy in postmenopausal patients (HYGREB-1): a multicenter, single-blind randomized clinical trial. Int J Gynaecol Obstet 155(3):425–432
Ørtoft G, Dueholm M, Mathiesen O, Hansen ES, Lundorf E, Møller C, Marinovskij E, Petersen LK (2013) Preoperative staging of endometrial cancer using TVS, MRI, and hysteroscopy. Acta Obstet Gynecol Scand 92(5):536–545
Lau S, Vaknin Z, Ramana-Kumar AV, Halliday D, Franco EL, Gotlieb WH (2012) Outcomes and cost comparisons after introducing a robotics program for endometrial cancer surgery. Obstet Gynecol 119(4):717–724
Casarin J, Multinu F, Ubl DS, Dowdy SC, Cliby WA, Glaser GE, Butler KA, Ghezzi F, Habermann EB, Mariani A (2018) Adoption of minimally invasive surgery and decrease in surgical morbidity for endometrial cancer treatment in the United States. Obstet Gynecol 131(2):304–311
Casarin J, Song C, Multinu F, Cappuccio S, Liu E, Butler KA, Glaser GE, Cliby WA, Langstraat CL, Ghezzi F, Habermann EB, Mariani A (2020) Implementing robotic surgery for uterine cancer in the United States: better outcomes without increased costs. Gynecol Oncol 156(2):451–458
Korsholm M, Mogensen O, Jeppesen MM, Lysdal VK, Traen K, Jensen PT (2017) Systematic review of same-day discharge after minimally invasive hysterectomy. Int J Gynaecol Obstet 136(2):128–137
Ellinides A, Manolopoulos PP, Hajymiri M, Sergentanis TN, Trompoukis P, Ntourakis D (2022) outpatient hysterectomy versus inpatient hysterectomy: a systematic review and meta-analysis. J Minim Invasive Gynecol 29(1):23-40.e7
Wasson MN, Butler KA, McLemore RY, Magrina JF (2015) Feasibility of minimally invasive outpatient hysterectomy. J Minim Invasive Gynecol 22(6S):S84–S85
Sanabria D, Rodriguez J, Pecci P, Ardila E, Pareja R (2020) Same-day discharge in minimally invasive surgery performed by gynecologic oncologists: a review of patient selection. J Minim Invasive Gynecol 27(4):816–825
Nahas S, Feigenberg T, Park S (2016) Feasibility and safety of same-day discharge after minimally invasive hysterectomy in gynecologic oncology: a systematic review of the literature. Gynecol Oncol 143(2):439–442
Lee J, Aphinyanaphongs Y, Curtin JP, Chern JY, Frey MK, Boyd LR (2016) The safety of same-day discharge after laparoscopic hysterectomy for endometrial cancer. Gynecol Oncol 142(3):508–513
Matern T, Kang E, Lim PC (2020) Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma. Gynecol Oncol 157(2):482–486
Schiavone MB, Herzog TJ, Ananth CV, Wilde ET, Lewin SN, Burke WM, Lu YS, Neugut AI, Hershman DL, Wright JD (2012) Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy. Am J Obstet Gynecol 207(5):382 e1-382 e9
Gien LT, Kupets R, Covens A (2011) Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology. Gynecol Oncol 121(2):339–343
Lee SJ, Calderon B, Gardner GJ, Mays A, Nolan S, Sonoda Y, Barakat RR, Leitao MM Jr (2014) The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications. Gynecol Oncol 133(3):552–555
Lee MS, Venkatesh KK, Growdon WB, Ecker JL, York-Best CM (2016) Predictors of 30-day readmission following hysterectomy for benign and malignant indications at a tertiary care academic medical center. Am J Obstet Gynecol 214(5):607 e1-607 e12
Son J, Tran T, Yao M, Michener CM (2021) Factors associated with unplanned admission in patients intended for same day discharge after minimally invasive hysterectomy for endometrial cancer. Surg Innov 29(3):336–342
Moawad G, Tyan P, Vargas V, Park D, Young H, Marfori C (2019) Predictors of overnight admission after minimally invasive hysterectomy in the expert setting. J Minim Invasive Gynecol 26(1):122–128
Penner KR, Fleming ND, Barlavi L, Axtell AE, Lentz SE (2015) Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies. Am J Obstet Gynecol 212(2):186 e1-188 e8
Fountain CR, Havrilesky LJ (2017) Promoting same-day discharge for gynecologic oncology patients in minimally invasive hysterectomy. J Minim Invasive Gynecol 24(6):932–939
Acknowledgements
None
Funding
NonE.
Author information
Authors and Affiliations
Contributions
AG contributed to conceptualization, data collection, and writing. JFM and KAB contributed to conceptualization, writing, editing, and supervision. PMM contributed to conceptualization, revision, and data collection.
Corresponding author
Ethics declarations
Conflict of interest
Andrea Giannini, Javier F. Magrina, Paul M. Magtibay, and Kristina A. Butler have no conflicts of interest or financial ties to disclose.
Research involving human participants and/or animals
The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinky (as revised in 2013). Institutional Review Board of Mayo Clinic approved the study protocol (#: 1764–05).
Informed consent
Informed consent was obtained from each patient prior to any procedure specific to clinical investigations.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Giannini, A., Magrina, J.F., Magtibay, P.M. et al. Same-day dismissal for endometrial cancer robotic surgery: feasibility factors. Updates Surg 75, 743–755 (2023). https://doi.org/10.1007/s13304-022-01424-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-022-01424-0